Erratum: High Mitochondrial Priming Sensitizes hESCs to DNA-Damage-Induced Apoptosis (Cell Stem Cell (2013) 13(4) (483–491) (S1934590913003639)(10.1016/j.stem.2013.07.018));High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis

Cell Stem Cell

Volumn 13, Issue 4, 2013, Pages 483-491

  Liu, Julia C ^a   Guan, Xiao ^b   Ryan, Jeremy A ^c   Rivera, Ana G ^a   Mock, Caroline ^a   Agarwal, Vishesh ^b   Letai, Anthony ^a,c   Lerou, Paul H ^b,d,e   Lahav, Galit ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; EMBRYONIC STEM CELL; GENE; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROGENY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION; CYTOLOGY; METABOLISM;

APOPTOSIS; DNA DAMAGE; EMBRYONIC STEM CELLS; HUMANS; MITOCHONDRIA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84885147908     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2013.10.004     Document Type: Erratum

References (33)

1. P.W. Andrews Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro Dev. Biol. 103 1984 285 293
2. T.R. Brummelkamp, R. Bernards, and R. Agami A system for stable expression of short interfering RNAs in mammalian cells Science 296 2002 550 553
3. M. Certo, V. Del Gaizo Moore, M. Nishino, G. Wei, S. Korsmeyer, S.A. Armstrong, and A. Letai Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members Cancer Cell 9 2006 351 365
4. J.E. Chipuk, L. Bouchier-Hayes, T. Kuwana, D.D. Newmeyer, and D.R. Green PUMA couples the nuclear and cytoplasmic proapoptotic function of p53 Science 309 2005 1732 1735
5. R. Dumitru, V. Gama, B.M. Fagan, J.J. Bower, V. Swahari, L.H. Pevny, and M. Deshmukh Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis Mol. Cell 46 2012 573 583
6. T.M. Filion, M. Qiao, P.N. Ghule, M. Mandeville, A.J. van Wijnen, J.L. Stein, J.B. Lian, D.C. Altieri, and G.S. Stein Survival responses of human embryonic stem cells to DNA damage J. Cell. Physiol. 220 2009 586 592
7. A.A. Filipczyk, A.L. Laslett, C. Mummery, and M.F. Pera Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells Stem Cell Res. (Amst.) 1 2007 45 60
8. C. Grandela, M.F. Pera, S.M. Grimmond, G. Kolle, and E.J. Wolvetang p53 is required for etoposide-induced apoptosis of human embryonic stem cells Stem Cell Res. (Amst.) 1 2007 116 128
9. D.R. Green, and G. Kroemer Cytoplasmic functions of the tumour suppressor p53 Nature 458 2009 1127 1130
10. A.V. Gudkov, and E.A. Komarova The role of p53 in determining sensitivity to radiotherapy Nat. Rev. Cancer 3 2003 117 129
11. E.A. Komarova, M.V. Chernov, R. Franks, K. Wang, G. Armin, C.R. Zelnick, D.M. Chin, S.S. Bacus, G.R. Stark, and A.V. Gudkov Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo EMBO J. 16 1997 1391 1400
12. M. Löbrich, A. Shibata, A. Beucher, A. Fisher, M. Ensminger, A.A. Goodarzi, O. Barton, and P.A. Jeggo gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization Cell Cycle 9 2010 662 669
13. O. Momcilovic, L. Knobloch, J. Fornsaglio, S. Varum, C. Easley, and G. Schatten DNA damage responses in human induced pluripotent stem cells and embryonic stem cells PLoS ONE 5 2010 e13410
14. M. Müller, S. Wilder, D. Bannasch, D. Israeli, K. Lehlbach, M. Li-Weber, S.L. Friedman, P.R. Galle, W. Stremmel, M. Oren, and P.H. Krammer p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs J. Exp. Med. 188 1998 2033 2045
15. K. Nakano, and K.H. Vousden PUMA, a novel proapoptotic gene, is induced by p53 Mol. Cell 7 2001 683 694
16. T. Ni Chonghaile, K.A. Sarosiek, T.-T. Vo, J.A. Ryan, A. Tammareddi, Vdel.G. Moore, J. Deng, K.C. Anderson, P. Richardson, and Y.-T. Tai Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy Science 334 2011 1129 1133
17. H. Niwa, J. Miyazaki, and A.G. Smith Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells Nat. Genet. 24 2000 372 376
18. K. O'Keefe, H. Li, and Y. Zhang Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination Mol. Cell. Biol. 23 2003 6396 6405
19. E. Oda, R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi, and N. Tanaka Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 288 2000 1053 1058
20. K. Oda, H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura, and Y. Taya p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 Cell 102 2000 849 862
21. H. Qin, T. Yu, T. Qing, Y. Liu, Y. Zhao, J. Cai, J. Li, Z. Song, X. Qu, and P. Zhou Regulation of apoptosis and differentiation by p53 in human embryonic stem cells J. Biol. Chem. 282 2007 5842 5852
22. T. Riley, E. Sontag, P. Chen, and A. Levine Transcriptional control of human p53-regulated genes Nat. Rev. Mol. Cell Biol. 9 2008 402 412
23. A.I. Robles, N.A. Bemmels, A.B. Foraker, and C.C. Harris APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis Cancer Res. 61 2001 6660 6664
24. Y. Shiloh, G.P. van der Schans, P.H. Lohman, and Y. Becker Induction and repair of DNA damage in normal and ataxia-telangiectasia skin fibroblasts treated with neocarzinostatin Carcinogenesis 4 1983 917 921
25. M.V. Sokolov, I.V. Panyutin, I.G. Panyutin, and R.D. Neumann Dynamics of the transcriptome response of cultured human embryonic stem cells to ionizing radiation exposure Mutat. Res. 709-710 2011 40 48
26. E.C. Thornborrow, S. Patel, A.E. Mastropietro, E.M. Schwartzfarb, and J.J. Manfredi A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes Oncogene 21 2002 990 999
27. C. Tse, A.R. Shoemaker, J. Adickes, M.G. Anderson, J. Chen, S. Jin, E.F. Johnson, K.C. Marsh, M.J. Mitten, and P. Nimmer ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor Cancer Res. 68 2008 3421 3428
28. L.T. Vassilev, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, and C. Klein In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 303 2004 844 848
29. A. Villunger, E.M. Michalak, L. Coultas, F. Müllauer, G. Böck, M.J. Ausserlechner, J.M. Adams, and A. Strasser p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa Science 302 2003 1036 1038
30. T.-T. Vo, J. Ryan, R. Carrasco, D. Neuberg, D.J. Rossi, R.M. Stone, D.J. Deangelo, M.G. Frattini, and A. Letai Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML Cell 151 2012 344 355
31. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
32. K.H. Vousden, and D.P. Lane p53 in health and disease Nat. Rev. Mol. Cell Biol. 8 2007 275 283
33. K.D. Wilson, N. Sun, M. Huang, W.Y. Zhang, A.S. Lee, Z. Li, S.X. Wang, and J.C. Wu Effects of ionizing radiation on self-renewal and pluripotency of human embryonic stem cells Cancer Res. 70 2010 5539 5548